Accueil / Tag Archives: New-York (page 4)

Tag Archives: New-York

The Valence Group conseille SK Capital pour l’acquisition de la division PP & S de PolyOne

Tuesday, October 29th 2019 at 2:57pm UTC NEW YORK–(BUSINESS WIRE)– Le groupe Valence a conseillé SK Capital lors de l’acquisition de la division Performance Products & Solutions de PolyOne Corporation qui se montait à 775 millions de dollars, faisant naître ainsi un nouveau leader des composés plastiques sous le nom …

Plus »

IVERIC bio Appoints Abraham Scaria, PhD, as Chief Scientific Officer

Tuesday, October 29th 2019 at 12:30pm UTC – Former Genzyme and Sanofi Scientist Brings Extensive Experience in Ocular Gene Therapy with Viral Vectors to IVERIC bio – NEW YORK–(BUSINESS WIRE)– IVERIC bio, Inc. (NASDAQ:ISEE) announced today the appointment of Abraham Scaria, PhD, to the position of Chief Scientific Officer, effective …

Plus »

Gotham Therapeutics Establishes Advanced Oncology Profiling Cascade with ProQinase to Progress its Portfolio of Epitranscriptomic Drug Candidates

Tuesday, October 29th 2019 at 1:00pm UTC Gotham’s pipeline covers the entire reader-writer-eraser paradigm with three lead programs advancing in parallel through preclinical discovery NEW YORK & FREIBURG, Germany–(BUSINESS WIRE)– Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, and ProQinase, an early stage drug-discovery company, …

Plus »

QIAGEN’s QuantiFERON®-TB Gold Plus Test Added to the Global Drug Facility Catalog for Public Health Efforts

Tuesday, October 29th 2019 at 9:05pm UTC QIAGEN expands market for gold standard latent TB test to help developing countries fight TB WHO-endorsed test to support communities with the highest need First demonstration of QuantiFERON®-TB Access at the Union World meeting in India HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)– QIAGEN …

Plus »

First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma

Tuesday, October 29th 2019 at 8:30pm UTC Cellectis’ UCARTCS1 MELANI-01 Trial Commenced at MD Anderson Cancer Center NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited off-the-shelf CAR T-cells (UCART), today announced the Company has dosed …

Plus »

IVERIC bio’s Zimura®, a Novel Complement C5 Inhibitor, Met its Primary Endpoint and Reached Statistical Significance in a Phase 2b Randomized, Controlled Clinical Trial in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Monday, October 28th 2019 at 10:30am UTC – Overall Data Suggest a Dose Response Relationship Across Treatment Groups – – Conference Call and Webcast Today, October 28, 2019 at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)– IVERIC bio, Inc. (Nasdaq: ISEE) today announced initial topline data confirming that Zimura® (avacincaptad …

Plus »

KORU Medical Systems Schedules 2019 Third Quarter Financial Results and Conference Call

Monday, October 28th 2019 at 1:05pm UTC CHESTER, N.Y.–(BUSINESS WIRE)– Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that it will release its financial results for the third quarter and nine months ended September 30, 2019 after the close of the financial markets on Tuesday, November …

Plus »

PFIZER REPORTS THIRD-QUARTER 2019 RESULTS

Tuesday, October 29th 2019 at 10:45am UTC Third-Quarter 2019 Revenues of $12.7 Billion, Reflecting 3% Operational Decline; Excluding the Impact from Consumer Healthcare(1), Third-Quarter 2019 Revenues were Flat Operationally – 9% Operational Growth from Biopharma (Pfizer RemainCo), Primarily Driven by Ibrance, Xeljanz, Eliquis, Vyndaqel and Inlyta as well as 15% …

Plus »

Ipsen Delivers Strong Double-digit Sales Growth for the Third Quarter of 2019 and Confirms Full Year 2019 Guidance

Thursday, October 24th 2019 at 5:00am UTC PARIS–(BUSINESS WIRE)– Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter of 2019. Financial highlights Q3 2019 Group sales growth of +16.0% as reported and +14.5%1 at constant exchange rates and consolidation scope, …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.